Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Lung
|
February 15, 2022
Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
Jamie L Todd, Megan L Neely, Robert Overton, et al.
American Heart Journal
|
October 18, 2024
Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease
Nishant P Shah, Hillary Mulder, Elizabeth Lydon, et al.
Nature Medicine
|
March 30, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Stefan D Anker, Mahir Karakas, Robert J Mentz, et al.
Circulation
|
November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Frederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
JAMA Network Open
|
January 16, 2019
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial
J Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, et al.
European Journal of Heart Failure
|
March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score
Christopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
BMJ Open
|
August 8, 2024
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial
Guillaume Marquis-Gravel, Hillary Mulder, Lisa M Wruck, et al.
Pediatric Cardiology
|
March 15, 2024
Risk Factors and Outcomes Associated with Gaps in Care in Children with Congenital Heart Disease
Michael B Rosamilia, Jason Williams, Courtney A Bair, et al.
European Journal of Heart Failure
|
May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial
Adriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of Cardiac Failure
|
July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
Robert J Mentz, Hillary Mulder, Arend Mosterd, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Lung
|
February 15, 2022
Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
Jamie L Todd, Megan L Neely, Robert Overton, et al.
American Heart Journal
|
October 18, 2024
Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease
Nishant P Shah, Hillary Mulder, Elizabeth Lydon, et al.
Nature Medicine
|
March 30, 2025
Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Stefan D Anker, Mahir Karakas, Robert J Mentz, et al.
Circulation
|
November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
Frederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
JAMA Network Open
|
January 16, 2019
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial
J Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, et al.
European Journal of Heart Failure
|
March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score
Christopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.
BMJ Open
|
August 8, 2024
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial
Guillaume Marquis-Gravel, Hillary Mulder, Lisa M Wruck, et al.
Pediatric Cardiology
|
March 15, 2024
Risk Factors and Outcomes Associated with Gaps in Care in Children with Congenital Heart Disease
Michael B Rosamilia, Jason Williams, Courtney A Bair, et al.
European Journal of Heart Failure
|
May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial
Adriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of Cardiac Failure
|
July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
Robert J Mentz, Hillary Mulder, Arend Mosterd, et al.
Page
of 8